Angel investing isn’t for the faint of heart, especially when valuations are at nosebleed levels. Before you delve into any specific opportunity, you may wish to take the pulse of the market into account.

You may also want to consider issues such as:

• What is different about Generation Z angel investors?
• What is the impact on angel investors of venture capitalists becoming increasingly involved in seed round investing?
• How can early-stage companies take defensive postures by being receptive to extension rounds, venture debt and warrants?
• What are the risks associated with Simple Agreements for Future Equity (SAFEs)?
• Why should investors be concerned about possible cramdowns and carve-outs?
• What can early-stage companies offer angel investors/groups to accelerate their decision making?
• What is the likelihood of Americans being allowed to fund their angel investments from their retirement accounts?

Ronald Weissman is the Vice Chairman and Board Member of the Angel Capital Association. He is the author of the ACA's courses on Assessing and Managing Risks in Early-Stage Investing.

With more than seventeen years in global venture capital and sixteen years in angel investing. He has recently advised investors, governments, corporate VCs and startups in locations as diverse as Armenia, Germany, Israel, the Republic of Georgia, Italy, Chile, Australia, New Zealand and across the US. He lectures on venture capital at major universities including Stanford, Santa Clara University, the American University of Armenia and the Deggendorf Institute of Technology, where he is an Adjunct Professor.